Aphria Germany (Tilray Germany)
About Aphria Germany (Tilray Germany)
Tilray Germany, formerly Aphria Germany, operates one of the most advanced medical cannabis production facilities in Europe, located in Neumünster, Schleswig-Holstein. The facility holds one of three BfArM domestic cultivation licenses and grows cannabis under EU-GMP conditions. As part of Tilray Brands, the operation serves as a key hub for European medical cannabis supply.
Key Facts
- 1Operates a purpose-built facility in Neumünster with BfArM cultivation license
- 2One of three domestic cannabis producers licensed in Germany
- 3Merged with Tilray in 2021 as part of the Aphria-Tilray merger
- 4Facility includes cultivation, processing, and packaging under one roof
Latest News
TLRY Stock Volatility Signals Broader Cannabis Sector Turbulence
Tilray's recent price swings reflect mounting pressures across cannabis equities as investors reassess sector fundamentals amid regulatory uncertainty.
Tilray Stock Plunges Despite Cannabis Rescheduling Progress
TLRY shares tumble as investors reassess reclassification timeline and competitive pressures in evolving regulatory landscape.
Frequently Asked Questions
What happened to Aphria Germany?
Aphria Germany became part of Tilray Brands following the merger of Aphria Inc. and Tilray Inc. in 2021. The Neumünster production facility continues to operate under the Tilray banner.
Does Tilray Germany export cannabis?
Yes, the Neumünster facility serves as a European hub for Tilray, producing and distributing medical cannabis to pharmacies in Germany and exporting to other European markets where Tilray operates.
Cannabis Laws
Products
- Domestically cultivated medical cannabis
- EU-GMP cannabis flowers
- Medical cannabis extracts
Specialties
Company Details
- Location
- Neumünster, Germany
- Founded
- 2018
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY